“…In the present study, KRT13 showed significantly down-regulated in OSCC as compared with non-OSCC. This finding was in concordance with a study by Lallemant et al (2009) using qPCR assay which concurred that KRT13 expression was found lower in the head and neck cancer tumour tissues as compared with normal tissues. In the immunohistochemical studies, KRT13 was 100% expressed in normal mucosa, mild and moderate oral epithelial dysplasia.…”